Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Dice Therapeutics Inc (DICE)
Dice Therapeutics Inc (DICE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,224,742
  • Shares Outstanding, K 47,731
  • Annual Sales, $ 0 K
  • Annual Income, $ -83,890 K
  • 60-Month Beta 0.69
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.05
Trade DICE with:

Options Overview Details

View History
  • Implied Volatility 16.84% ( -1.78%)
  • Historical Volatility 97.99%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 240.01% on 10/04/22
  • IV Low 16.84% on 06/23/23
  • Put/Call Vol Ratio 4.09
  • Today's Volume 331
  • Volume Avg (30-Day) 1,858
  • Put/Call OI Ratio 1.52
  • Today's Open Interest 26,192
  • Open Int (30-Day) 5,133

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.65
  • Number of Estimates 4
  • High Estimate -0.59
  • Low Estimate -0.72
  • Prior Year -0.58
  • Growth Rate Est. (year over year) -12.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.58 +57.88%
on 06/05/23
46.75 -0.11%
on 06/20/23
+12.59 (+36.91%)
since 05/23/23
3-Month
25.51 +83.07%
on 04/04/23
46.75 -0.11%
on 06/20/23
+19.90 (+74.25%)
since 03/23/23
52-Week
14.41 +223.97%
on 07/13/22
46.75 -0.11%
on 06/20/23
+30.96 (+196.70%)
since 06/23/22

Most Recent Stories

More News
Why Dice Therapeutics Stock Bolted Higher This Week

The small-cap drugmaker fetched a hefty premium in a buyout deal with Eli Lilly.

PFE : 38.30 (-1.11%)
DICE : 46.70 (+0.19%)
LLY : 458.84 (+0.25%)
Is Eli Lilly's Dice Therapeutics Acquisition a Needle-Moving Event?

The pharma giant's latest acquisition might be on the small side, but it could yield an important new growth driver in the years ahead.

LLY : 458.84 (+0.25%)
DICE : 46.70 (+0.19%)
Red Hot Eli Lilly Rolls the DICE With Its Latest Biotech Takeover

The market’s initial positive reaction to the DICE Therapeutics news suggests Eli Lilly shares will continue to sizzle this summer.

LLY : 458.84 (+0.25%)
DICE : 46.70 (+0.19%)
JNJ : 165.48 (-0.08%)
MRK : 114.60 (+0.77%)
Stocks End Moderately Lower Ahead of Powell’s Testimony to Congress

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.72%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed...

$SPX : 4,348.33 (-0.77%)
SPY : 433.21 (-0.76%)
$DOWI : 33,727.43 (-0.65%)
DIA : 337.16 (-0.64%)
$IUXX : 14,891.48 (-1.00%)
QQQ : 362.54 (-0.99%)
HAL : 30.89 (-1.22%)
DVN : 47.15 (-1.13%)
PSX : 90.86 (+0.06%)
APA : 32.58 (-1.90%)
CVX : 151.35 (-0.85%)
COP : 100.46 (-0.96%)
Eli Lilly's $2.4 Billion Acquisition of Dice Therapeutics: What Investors Need to Know

Lilly could get a couple of promising autoimmune-disease drugs with the transaction.

LLY : 458.84 (+0.25%)
DICE : 46.70 (+0.19%)
Moore Kuehn Encourages SURF, NEX, NETI, and DICE Investors to Contact Law Firm

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

SURF : 0.8300 (-3.49%)
NEX : 8.40 (-2.33%)
NETI : 11.65 (-1.77%)
DICE : 46.70 (+0.19%)
Eli Lilly (NYSE: LLY) Acquires DICE Therapeutics (NASDAQ: DICE): A New Step in Autoimmune Disease Treatments

Eli Lilly and Company (NYSE: LLY) has announced a definitive agreement to acquire DICE Therapeutics, Inc. (NASDAQ: DICE), a biopharmaceutical company known for its DELSCAPE technology platform and oral...

LLY : 458.84 (+0.25%)
DICE : 46.70 (+0.19%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, NETI, DICE

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

KDNY : 38.30 (+0.03%)
NETI : 11.65 (-1.77%)
DICE : 46.70 (+0.19%)
Why Shares of Dice Therapeutics Are Skyrocketing Tuesday

The company received a buyout offer from Eli Lilly.

DICE : 46.70 (+0.19%)
LLY : 458.84 (+0.25%)
Stocks Fall on Chinese Economic Concerns and Wariness Ahead of Fed Chair Powell

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.77%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.88%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.73%....

$SPX : 4,348.33 (-0.77%)
SPY : 433.21 (-0.76%)
$DOWI : 33,727.43 (-0.65%)
DIA : 337.16 (-0.64%)
$IUXX : 14,891.48 (-1.00%)
QQQ : 362.54 (-0.99%)
APA : 32.58 (-1.90%)
HAL : 30.89 (-1.22%)
DVN : 47.15 (-1.13%)
MRO : 21.95 (-1.35%)
VLO : 111.30 (+0.82%)
CVX : 151.35 (-0.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

DICE Therapeutics Inc. is a biopharmaceutical company. Its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. DICE Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

See More

Key Turning Points

3rd Resistance Point 46.96
2nd Resistance Point 46.84
1st Resistance Point 46.77
Last Price 46.70
1st Support Level 46.58
2nd Support Level 46.46
3rd Support Level 46.39

See More

52-Week High 46.75
Last Price 46.70
Fibonacci 61.8% 34.40
Fibonacci 50% 30.58
Fibonacci 38.2% 26.77
52-Week Low 14.41

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar